Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide mesylate and neuroplasticity in Parkinson's disease
jRCTs061220070Recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of safinamide in Parkinson's disease (PD) (2 arms), sponsored by Eisai Co., Ltd. Started Apr 2023; status: recruiting.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCTs061220070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061220070.